ABG

Ally Bridge Group Portfolio holdings

AUM $119M
1-Year Est. Return 78.04%
This Quarter Est. Return
1 Year Est. Return
+78.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$119M
AUM Growth
+$5.08M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$15M
2
+$12.1M
3
+$10.2M
4
SLNO icon
Soleno Therapeutics
SLNO
+$8.36M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$6.21M

Top Sells

1
+$15.2M
2
+$7.82M
3
+$7.37M
4
ELVN icon
Enliven Therapeutics
ELVN
+$5.64M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$4.93M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$1.27B
– –
-281,394
GERN icon
27
Geron
GERN
$798M
– –
-3,251,475
PRAX icon
28
Praxis Precision Medicines
PRAX
$4.86B
– –
-80,880
RARE icon
29
Ultragenyx Pharmaceutical
RARE
$3.55B
– –
0
REPL icon
30
Replimune Group
REPL
$821M
– –
-528,491
RNA icon
31
Avidity Biosciences
RNA
$10.8B
– –
-132,744
VRNA
32
DELISTED
Verona Pharma
VRNA
– –
-160,701
ATYR
33
aTyr Pharma
ATYR
$81.4M
– –
-287,720
1
2